Pleiotrophin inhibits HIV infection by binding the cell surface-expressed nucleolin

FEBS Journal

Volumn 272, Issue 18, 2005, Pages 4646-4659

  Said, Elias A ^a   Courty, José ^b   Svab, Josette ^a   Delbé, Jean ^b   Krust, Bernard ^a   Hovanessian, Ara G ^a  

^a CNRS   (France)

^b Université Paris Val de Marne ^*  (France)

Author keywords

Binding; HIV; Pleiotrophin; Receptor; Surface nucleolin

Indexed keywords

AMINO ACID; HEPARAN; NUCLEOLIN; PLEIOTROPHIN; PROTEOCHONDROITIN SULFATE; PSEUDOPEPTIDE;

ARTICLE; BINDING AFFINITY; BINDING SITE; CELL SURFACE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CROSS LINKING; DRUG INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMINO ACID SEQUENCE; CARRIER PROTEINS; CYTOKINES; ENDOCYTOSIS; HELA CELLS; HEPARAN SULFATE PROTEOGLYCANS; HIV; HIV INFECTIONS; HUMANS; MEMBRANE PROTEINS; PEPTIDE FRAGMENTS; PHOSPHOPROTEINS; PROTEIN BINDING; PROTEOCHONDROITIN SULFATES; RNA-BINDING PROTEINS; TEMPERATURE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 25444530635     PISSN: 1742464X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2005.04870.x     Document Type: Article

References (62)

1. Alkhatib G, Locati M, Kennedy PE, Murphy PM & Berger EA (1997) HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: independence from G protein signaling and importance of coreceptor down-modulation. Virology 234, 340-348.
2. Farzan M, Choe H, Desjardins E, Sun Y, Kuhn J, Cao J, Archambault D, Kolchinsky P, Koch M, Wyatt R & Sodroski J (1998) Stabilization of human immunodeficiency virus type 1 envelope glycoprotein trimers by disulfide bonds introduced into the gp41 glycoprotein ectodomain. J Virol 72, 7620-7625.
3. Callebaut C, Blanco J, Benkirane N, Krust B, Jacotot E, Guichard G, Seddiki N, Svab J, Dam E, Muller S, Briand JP & Hovanessian AG (1998) Identification of V3 loop-binding proteins as potential receptors implicated in the binding of HIV particles to CD4(+) cells. J Biol Chem 273, 21988-21997.
4. Nisole S, Krust B, Callebaut C, Guichard G, Muller S, Briand JP & Hovanessian AG (1999) The anti-HIV pseudopeptide HB-19 forms a complex with the cell-surface-expressed nucleolin independent of heparan sulfate proteoglycans. J Biol Chem 274, 27875-27884.
5. Nisole S, Krust B & Hovanessian AG (2002) Anchorage of HIV on permissive cells leads to coaggregation of viral particles with surface nucleolin at membrane raft microdomains. Exp Cell Res 276, 155-173.
6. Mondor I, Ugolini S & Sattentau QJ (1998) Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and requires cell surface heparans. J Virol 72, 3623-3634.
7. Saphire AC, Bobardt MD & Gallay PA (1999) Host cyclophilin A mediates HIV-1 attachment to target cells via heparans. EMBO J 18, 6771-6785.
8. Said EA, Krust B, Nisole S, Svab J, Briand JP & Hovanessian AG (2002) The anti-HIV cytokine midkine binds the cell surface-expressed nucleolin as a low affinity receptor. J Biol Chem 277, 37492-37502.
9. Legrand D, Vigie K, Said EA, Elass E, Masson M, Slomianny MC, Carpentier M, Briand JP, Mazurier J & Hovanessian AG (2004) Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells. Eur J Biochem 271, 303-317.
10. Milner PG, Li YS, Hoffman RM, Kodner CM, Siegel NR & Deuel TF (1989) A novel 17 kD heparin-binding growth factor (HBGF-8) in bovine uterus: purification and N-terminal amino acid sequence. Biochem Biophys Res Commun 165, 1096-1103.
11. Merenmies J & Rauvala H (1990) Molecular cloning of the 18-kDa growth-associated protein of developing brain. J Biol Chem 265, 16721-16724.
12. Kuo MD, Oda Y, Huang JS & Huang SS (1990) Amino acid sequence and characterization of a heparin-binding neurite-promoting factor (p18) from bovine brain. J Biol Chem 265, 18749-18752.
13. Courty J, Dauchel MC, Caruelle D, Perderiset M & Barritault D (1991) Mitogenic properties of a new endothelial cell growth factor related to pleiotrophin. Biochem Biophys Res Commun. 180, 145-151.
14. Deuel TF, Zhang N, Yeh HJ, Silos-Santiago I & Wang ZY (2002) Pleiotrophin: a cytokine with diverse functions and a novel signaling pathway. Arch Biochem Biophys 397, 162-171.
15. Aigner A, Brachmann P, Beyer J, Jager R, Raulais D, Vigny M, Neubauer A, Heidenreich A, Weinknecht S, Czubayko F & Zugmaier G (2003) Marked increase of the growth factors pleiotrophin and fibroblast growth factor-2 in serum of testicular cancer patients. Ann Oncol 14, 1525-1529.
16. Souttou B, Juhl H, Hackenbruck J, Rockseisen M, Klomp HJ, Raulais D, Vigny M & Wellstein A (1998) Relationship between serum concentrations of the growth factor pleiotrophin and pleiotrophin-positive tumors. J Natl Cancer Inst 90, 1468-1473.
17. Czubayko F, Schulte AM, Missner SC, Hsieh SS, Colley KJ & Wellstein A (1995) Molecular and pharmacologic targeting of angiogenesis factors - the example of pleiotrophin. Breast Cancer Res Treat 36, 157-168.
18. Petersen W, Wildemann B, Pufe T, Raschke M & Schmidmaier G (2003) The angiogenic peptide pleiotrophin (PTN/HB-GAM) is expressed in fracture healing: an immunohistochemical study in rats. Arch Orthop Trauma Surg 30, 30.
19. Sugino T, Kusakabe T, Hoshi N, Yamaguchi T, Kawaguchi T, Goodison S, Sekimata M, Homma Y & Suzuki T (2002) An invasion-independent pathway of blood-borne metastasis: a new murine mammary tumor model. Am J Pathol 160, 1973-1980.
20. Yeh HJ, He YY, Xu J, Hsu CY & Deuel TF (1998) Upregulation of pleiotrophin gene expression in developing microvasculature, macrophages, and astrocytes after acute ischemic brain injury. J Neurosci 18, 3699-3707.
21. Pufe T, Bartscher M, Petersen W, Tillmann B & Mentlein R (2003) Pleiotrophin, an embryonic differentiation and growth factor, is expressed in osteoarthritis. Osteoarthritis Cartilage 11, 260-264.
22. Pufe T, Bartscher M, Petersen W, Tillmann B & Mentlein R (2003) Expression of pleiotrophin, an embryonic growth and differentiation factor, in rheumatoid arthritis. Arthritis Rheum 48, 660-667.
23. Ostrander M, Fingar H, Seddon A, Bohlen P & Backer J (1992) Anti-viral activity of human recombinant heparin-binding proteins HBNF and MK. Biochem Biophys Res Commun 189, 1189-1195.
24. Raulo E, Chernousov MA, Carey DJ, Nolo R & Rauvala H (1994) Isolation of a neuronal cell surface receptor of heparin binding growth-associated molecule (HB-GAM). Identification as N-syndecan (syndecan-3). J Biol Chem 269, 12999-13004.
25. Meng K, Rodriguez-Pena A, Dimitrov T, Chen W, Yamin M, Noda M & Deuel TF (2000) Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta. Proc Natl Acad Sci USA 97, 2603-2608.
26. Tanaka M, Maeda N, Noda M & Marunouchi T (2003) A chondroitin sulfate proteoglycan PTPzeta/RPTPbeta regulates the morphogenesis of Purkinje cell dendrites in the developing cerebellum. J Neurosci 23, 2804-2814.
27. Stoica GE, Kuo A, Aigner A, Sunitha I, Souttou B, Malerczyk C, Caughey DJ, Wen D, Karavanov A, Riegel AT & Wellstein A (2001) Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin. J Biol Chem 276, 16772-16779.
28. Iwasaki W, Nagata K, Hatanaka H, Inui T, Kimura T, Muramatsu T, Yoshida K, Tasumi M & Inagaki F (1997) Solution structure of midkine, a new heparin-binding growth factor. EMBO J 16, 6936-6946.
29. Kurtz A, Schulte AM & Wellstein A (1995) Pleiotrophin and midkine in normal development and tumor biology. Crit Rev Oncog 6, 151-177.
30. Muramatsu T (2002) Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis. J Biochem (Tokyo) 132, 359-371.
31. Muramatsu T (1993) Midkine (MK), the product of a retinoic acid responsive gene, and pleiotrophin constitute a new protein family regulating growth and differentiation. Int J Dev Biol 37, 183-188.
32. Kurosawa N, Kadomatsu K, Ikematsu S, Sakuma S, Kimura T & Muramatsu T (2000) Midkine binds specifically to sulfatide the role of sulfatide in cell attachment to midkine-coated surfaces. Eur J Biochem 267, 344-351.
33. Zou K, Muramatsu H, Ikematsu S, Sakuma S, Salama RH, Shinomura T, Kimata K & Muramatsu T (2000) A heparin-binding growth factor, midkine, binds to a chondroitin sulfate proteoglycan, PG-M/versican. Eur J Biochem 267, 4046-4053.
34. Stoica GE, Kuo A, Powers C, Bowden ET, Sale EB, Riegel AT & Wellstein A (2002) Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types. J Biol Chem 277, 35990-35998.
35. Callebaut C, Nisole S, Briand JP, Krust B & Hovanessian AG (2001) Inhibition of HIV infection by the cytokine midkine. Virology 281, 248-264.
36. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR & Landau NR (1996) Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661-666.
37. Nisole S, Krust B, Dam E, Bianco A, Seddiki N, Loaec S, Callebaut C, Guichard G, Muller S, Briand JP & Hovanessian AG (2000) The HB-19 pseudopeptide 5[KΨ (CH2N) PR]-TASP inhibits attachment of T lymphocyte- and macrophage-tropic HIV to permissive cells. AIDS Res Hum Retroviruses 16, 237-249.
38. Esko JD, Rostand KS & Weinke JL (1988) Tumor formation dependent on proteoglycan biosynthesis. Science 241, 1092-1096.
39. Esko JD, Weinke JL, Taylor WH, Ekborg G, Roden L, Anantharamaiah G & Gawish A (1987) Inhibition of chondroitin and heparan sulfate biosynthesis in Chinese hamster ovary cell mutants defective in galactosyltransferase I. J Biol Chem 262, 12189-12195.
40. Bernard-Pierrot I, Ricol D, Cassidy A, Graham A, Elvin P, Caillault A, Lair S, Broet P, Thiery JP & Radvanyi F (2004) Inhibition of human bladder tumour cell growth by fibroblast growth factor receptor 2b is independent of its kinase activity. Involvement of the carboxy-terminal region of the receptor. Oncogene 23, 9201-9211.
41. Bernard-Pierrot I, Delbe J, Caruelle D, Barritault D, Courty J & Milhiet PE (2001) The lysine-rich C-terminal tail of heparin affin regulatory peptide is required for mitogenic and tumor formation activities. J Biol Chem 276, 12228-12234.
42. Krust B, Callebaut C & Hovanessian AG (1993) Inhibition of entry of HIV into cells by poly (A) poly (U). AIDS Res Hum Retroviruses 9, 1087-1090.
43. Marechal V, Clavel F, Heard JM & Schwartz O (1998) Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1. J Virol 72, 2208-2212.
44. Heroult M, Bernard-Pierrot I, Delbe J, Hamma-Kourbali Y, Katsoris P, Barritault D, Papadimitriou E, Plouet J & Courty J (2004) Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. Oncogene 23, 1745-1753.
45. Roghani M & Moscatelli D (1992) Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms. J Biol Chem 267, 22156-22162.
46. Take M, Tsutsui J, Obama H, Ozawa M, Nakayama T, Maruyama I, Arima T & Muramatsu T (1994) Identification of nucleolin as a binding protein for midkine (MK) and heparin-binding growth associated molecule (HB-GAM). J Biochem (Tokyo) 116, 1063-1068.
47. Vacherot F, Delbe J, Heroult M, Barritault D, Fernig DG & Courty J (1999) Glycosaminoglycans differentially bind HARP and modulate its biological activity. J Biol Chem 274, 7741-7747.
48. Ugolini S, Mondor I & Sattentau QJ (1999) HIV-1 attachment: another look. Trends Microbiol 7, 144-149.
49. Roderiquez G, Oravecz T, Yanagishita M, Bou-Habib DC, Mostowski H & Norcross MA (1995) Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41. J Virol 69, 2233-2239.
50. Larrucea S, Gonzalez-Rubio C, Cambronero R, Ballou B, Bonay P, Lopez-Granados E, Bouvet P, Fontan G, Fresno M & Lopez-Trascasa M (1998) Cellular adhesion mediated by factor J, a complement inhibitor. Evidence for nucleolin involvement. J Biol Chem 273, 31718-31725.
51. Kleinman HK, Weeks BS, Cannon FB, Sweeney TM, Sephel GC, Clement B, Zain M, Olson MO, Jucker M & Burrous BA (1991) Identification of a 110-kDa non-integrin cell surface laminin-binding protein which recognizes an A chain neurite-promoting peptide. Arch Biochem Biophys 290, 320-325.
52. De Verdugo UR, Selinka HC, Huber M, Kramer B, Kellermann J, Hofschneider PH & Kandolf R (1995) Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses. J Virol 69, 6751-6757.
53. Bose S, Basu M & Banerjee AK (2004) Role of nucleolin in human parainfluenza virus type 3 infection of human lung epithelial cells. J Virol 78, 8146-8158.
54. Pfeifle J & Anderer FA (1983) Localization of phosphoprotein PP 105 in cell lines of various species. Biochem Biophys Res Commun 116, 106-112.
55. Hovanessian AG, Puvion-Dutilleul F, Nisole S, Svab J, Perret E, Deng JS & Krust B (2000) The cell-surface-expressed nucleolin is associated with the actin cytoskeleton. Exp Cell Res 261, 312-328.
56. Muramatsu T (2002) Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis. J Biochem (Tokyo) 132, 359-371.
57. Pufe T, Bartscher M, Petersen W, Tillmann B & Mentlein R (2003) Expression of pleiotrophin, an embryonic growth and differentiation factor, in rheumatoid arthritis. Arthritis Rheum 48, 660-667.
58. Pufe T, Bartscher M, Petersen W, Tillmann B & Mentlein R (2003) Pleiotrophin, an embryonic differentiation and growth factor, is expressed in osteoarthritis. Osteoarthritis Cartilage 11, 260-264.
59. Czubayko F, Schulte AM, Missner SC, Hsieh SS, Colley KJ & Wellstein A (1995) Molecular and pharmacologic targeting of angiogenesis factors - the example of pleiotrophin. Breast Cancer Res Treat 36, 157-168.
60. Souttou B, Juhl H, Hackenbruck J, Rockseisen M, Klomp HJ, Raulais D, Vigny M & Wellstein A (1998) Relationship between serum concentrations of the growth factor pleiotrophin and pleiotrophin-positive tumors. J Natl Cancer Inst 90, 1468-1473.
61. Aigner A, Brachmann P, Beyer J, Jager R, Raulais D, Vigny M, Neubauer A, Heidenreich A, Weinknecht S, Czubayko F & Zugmaier G (2003) Marked increase of the growth factors pleiotrophin and fibroblast growth factor-2 in serum of testicular cancer patients. Ann Oncol 14, 1525-1529.
62. Petersen W, Wildemann B, Pufe T, Raschke M & Schmidmaier G (2004) The angiogenic peptide pleiotrophin (PTN/HB-GAM) is expressed in fracture healing: an immunohistochemical study in rats. Arch Orthop Trauma Surg 124, 603-607.